MultiCell Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MCET research report →
Price Chart
About the company
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health.
- CEO
- W. Gerald Newmin
- IPO
- 2000
- Employees
- 2
- HQ
- Woonsocket, RI, US
Get TickerSpark's AI analysis on MCET
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $500.10K
- P/E
- -1.00
- PEG
- 0.01
- P/S
- 10140.21
- P/B
- -3.14
- EV/EBITDA
- -0.97
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -1465.60%
- Net Margin
- -770.65%
- ROE
- 164.07%
- ROIC
- 81.33%
Latest fiscal year · YoY change
- Revenue
- $49.318+0.0%
- Gross Profit
- $49.318+0.0%
- Op Income
- $-722.807
- Net Income
- $-380.071+69.2%
- EPS
- $-0.00+83.3%
- OCF Growth
- +13.0%
- FCF Growth
- +13.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -8.86
- RSI (14)
- 41
- Avg Volume
- 3.20K
No earnings-call transcripts are available for MCET yet.
- Free Float
- 90.0%
- Shares Outstanding
- 5.00B
- Float Shares
- 4.50B
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 15, 14 | Sigmond Edward | other | 4,600,000 |
| Jan 15, 14 | PAGE THOMAS | other | 4,600,000 |
| Jan 15, 14 | NEWMIN W GERALD | other | 4,600,000 |
| Jan 15, 14 | MILLER GRANT | other | 4,600,000 |
| Jan 15, 14 | Chang Stephen | other | 4,600,000 |
| Jan 7, 14 | NEWMIN W GERALD | buy | 1,667,000 |
| Aug 16, 13 | Sigmond Edward | other | 5,000,000 |
| Aug 16, 13 | PAGE THOMAS | other | 5,000,000 |
| Aug 16, 13 | NEWMIN W GERALD | other | 5,000,000 |
| Aug 16, 13 | MILLER GRANT | other | 5,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MCET coverage
Recent articles, reports, and earnings notes.
No research on MCET yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MCET report →